Use of brain natriuretic peptide to detect previously unknown left ventricular dysfunction in patients with acute exacerbation of chronic obstructive pulmonary disease

Swiss Medical Weekly

Volumn 141, Issue NOVEMBER, 2011, Pages

  Gariani, Karim ^a   Delabays, Alain ^b   Perneger, Thomas V ^a   Agoritsas, Thomas ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Morges Hospital   (Switzerland)

Author keywords

B natriuretic peptide; Chronic obstructive pulmonary disease; Diagnosis; Exacerbation; Left ventricular dysfunction, acute heart failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC TEST; DIASTOLIC DYSFUNCTION; DISEASE EXACERBATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SYSTOLIC DYSFUNCTION; BLOOD; HEART LEFT VENTRICLE FUNCTION; MEDICAL AUDIT; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MEDICAL AUDIT; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 82655169295     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2011.13298     Document Type: Article

References (19)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349:1498-504. (Pubitemid 27216360)
2. Rutten FH, Cramer MJ, Lammers JW, Grobbee DE, Hoes AW. Heart failure and chronic obstructive pulmonary disease: An ignored combination? Eur J Heart Fail. 2006;8:706-11. (Pubitemid 44635314)
3. Rutten FH, Moons KG, Cramer MJ, et al. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ. 2005;331:1379.
4. Havranek EP, Masoudi FA, Westfall KA, Wolfe P, Ordin DL, Krumholz HM. Spectrum of heart failure in older patients: results from the National Heart Failure project. Am Heart J. 2002;143:412-7. (Pubitemid 34187650)
5. Curkendall SM, DeLuise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol. 2006;16:63-70. (Pubitemid 41783891)
6. Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increase preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003;42:1226-33. (Pubitemid 37188347)
7. Le Jemtel TH, Padeletti M, Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol. 2007;49:171-80. (Pubitemid 46054390)
8. Rutten FH, Cramer MJ, Zuithoff NP, et al. Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease. Eur J Heart Fail. 2007;9:651-9. (Pubitemid 46711268)
9. Render ML, Weinstein AS, Blaustein AS. Left ventricular dysfunction in deteriorating patients with chronic obstructive pulmonary disease. Chest. 1995;107;162-8.
10. Rutten FH, Cramer MJ, Grobbee DE, et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J. 2005;26:1887-94. (Pubitemid 41253302)
11. Worster A, Balion CM, Hill SA, et al. Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: a systematic review. Clin Biochem. 2008;41:250-9. (Pubitemid 351249854)
12. Mueller C, Laule-Kilian K, Schindler C, et al. Cost-effectiveness of B-type natriuretic peptides testing in patients with acute dyspnea. Arch Intern Med. 2006;166:1081-7. (Pubitemid 43765179)
13. Mueller C, Laule-Kilian K, Frana B, et al. Use of B-type natriuretic peptides in the management of acute dyspnea in patients with pulmonary disease. Am Heart J. 2006;151:471-7. (Pubitemid 43144752)
14. Abroug F, Ouanes-Bebes L. Detection of acute heart failure in chronic obstructive pulmonary disease patients: role of B-type natriuretic peptide. Current Opin Crit Care. 2008;14:340-7. (Pubitemid 351667921)
15. Mueller C, Breidthardt T, Laule-Kilian K, Christ M, Perruchoud AP. The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly. 2007;137(1-2):4-12. (Pubitemid 46191225)
16. McCullough PA, Duc P, Omland T, et al. Breathing Not Properly Multinational Study Investigators. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med. 2003;10:198-204. (Pubitemid 36292619)
17. Tung RH, Camargo CA Jr, Krauser D, Anwaruddin S, Baggish A, Chen A, et al. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease. Ann Emerg Med. 2006;48:66-74. (Pubitemid 43867056)
18. Abroug F, Ouanes-Besbes L, Nciri N, et al. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers. Am J Respir Crit Care Med. 2006;174:990-6. (Pubitemid 44684447)
19. Eurlings LW, van Pol PE, Kok WE, et al. Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study. J Am Coll Cardiol. 2010;56:2090-100.